AKTX - Akari Therapeutics PLC logo

AKTX

Akari Therapeutics PLC

Rev โ€”top 1%10Y
Hold

Akari Therapeutics develops antibody-drug conjugates (ADCs) targeting cancer. Its lead candidate, AKTX-101, targets solid tumors by combining a cancer-killing payload with antibodies. The company aims to address various cancer types through innovative therapies.

โš•๏ธ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago โ†’$1today

Score Overview

1 Year
Scoreโ€”
Net Growth-62.15%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-60.97%
Net Trend40%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-54.61%
Net Trend40%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency
All Time
Scoreโ€”
Net Growth38.11%
Net Trend45%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency

See the full market ranking โ†’

Akari Therapeutics PLC fundamental performance

Across Akari Therapeutics PLC's full reported history, from 2015 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 45M to -$ 17M. Revenue increased in 0% of the years measured; net income in 45%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 7.18โ€”
1 Year2025-08-12
$ 40.80-82.40%
5 Years2021-08-12
$ 1.37K-99.48%
10 Years2016-08-12
$ 7.36K-99.90%
All Time2015-09-21
$ 25.2K-99.97%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 28M$ 2M
2025$ 0.00-$ 17M$ 5M
2024$ 0.00-$ 19M$ 2M
2023$ 0.00-$ 10M$ 3M
2022$ 0.00-$ 17M$ 13M
2021$ 0.00-$ 17M$ 9M
2020$ 0.00-$ 17M$ 14M
2019$ 0.00-$ 16M$ 5M
2018$ 0.00-$ 19M$ 5M
2017$ 0.00-$ 27M$ 28M
2016$ 0.00-$ 18M$ 44M
IPO2015$ 0.00-$ 45M$ 68M

Explore beyond AKTX

You're looking at Akari Therapeutics PLC. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies